In Vitro and in Vivo Anticancer Activity of Copper Bis(thiosemicarbazone) Complexes

作者: Duraippandi Palanimuthu , Sridevi Vijay Shinde , Kumaravel Somasundaram , Ashoka G. Samuelson

DOI: 10.1021/JM300938R

关键词: ApoptosisZincDNA synthesisCell cultureStereochemistryCopperIn vivoSemicarbazoneIn vitroChemistry

摘要: Neutral and cationic copper bis(thiosemicarbazone) complexes bearing methyl, phenyl, hydrogen, on the diketo-backbone of ligand have been synthesized. All them were characterized by spectroscopic methods in three cases X-ray crystallography. In vitro cytotoxicity studies revealed that they are cytotoxic unlike corresponding zinc complexes. Copper Cu(GTSC) Cu(GTSCHCl) derived from glyoxal-bis(4-methyl-4-phenyl-3-thiosemicarbazone) (GTSCH(2)) most against various human cancer cell lines, with a potency similar to anticancer drug adriamycin up 1000 fold higher than complex. Tritiated thymidine incorporation assay inhibit DNA synthesis substantially. Cell cycle analyses showed induce apoptosis HCT116 cells. The complex caused distinct cleavage Topo II alpha inhibition for Cu(GTSC). vivo administration significantly inhibits tumor growth xenografts nude mice.

参考文章(67)
Narendra Wajapeyee, Ramona Britto, Halasahalli M. Ravishankar, Kumaravel Somasundaram, Apoptosis Induction by Activator Protein 2α Involves Transcriptional Repression of Bcl-2 Journal of Biological Chemistry. ,vol. 281, pp. 16207- 16219 ,(2006) , 10.1074/JBC.M600539200
Sofia I. Pascu, Philip A. Waghorn, Timothy D. Conry, Bonita Lin, Helen M. Betts, Jonathan R. Dilworth, Robert B. Sim, Grant C. Churchill, Franklin I. Aigbirhio, John E. Warren, Cellular confocal fluorescence studies and cytotoxic activity of new Zn(II) bis(thiosemicarbazonato) complexes. Dalton Transactions. ,vol. 2008, pp. 2107- 2110 ,(2008) , 10.1039/B802806K
Erika De Moliner, Stefano Moro, Stefania Sarno, Giuseppe Zagotto, Giuseppe Zanotti, Lorenzo A. Pinna, Roberto Battistutta, Inhibition of Protein Kinase CK2 by Anthraquinone-related Compounds Journal of Biological Chemistry. ,vol. 278, pp. 1831- 1836 ,(2003) , 10.1074/JBC.M209367200
Jason P. Holland, Peter J. Barnard, David Collison, Jonathan R. Dilworth, Ruth Edge, Jennifer C. Green, Eric J. L. McInnes, Spectroelectrochemical and Computational Studies on the Mechanism of Hypoxia Selectivity of Copper Radiopharmaceuticals Chemistry: A European Journal. ,vol. 14, pp. 5890- 5907 ,(2008) , 10.1002/CHEM.200800539
Cara A. Rabik, M. Eileen Dolan, Molecular mechanisms of resistance and toxicity associated with platinating agents Cancer Treatment Reviews. ,vol. 33, pp. 9- 23 ,(2007) , 10.1016/J.CTRV.2006.09.006
Y. N. Vashisht Gopal, Anand K. Kondapi, Topoisomerase II poisoning by indazole and imidazole complexes of ruthenium Journal of Biosciences. ,vol. 26, pp. 271- 276 ,(2001) , 10.1007/BF02703651
Amy L. Vāvere, Jason S. Lewis, Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia Dalton Transactions. pp. 4893- 4902 ,(2007) , 10.1039/B705989B
E. R. Dilanyan, T. R. Ovsepyan, F. G. Arsenyan, G. M. Stepanyan, B. T. Garibdzhanyan, Antitumor activity of substituted methylglyoxal bisthiosemicarbazones and their copper(II) chelates Pharmaceutical Chemistry Journal. ,vol. 42, pp. 504- 506 ,(2008) , 10.1007/S11094-009-0162-X
Brett M. Paterson, Paul S. Donnelly, Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals Chemical Society Reviews. ,vol. 40, pp. 3005- 3018 ,(2011) , 10.1039/C0CS00215A
Philip J. Blower, Thomas C. Castle, Andrew R. Cowley, Jonathan R. Dilworth, Paul S. Donnelly, Elena Labisbal, Frank E. Sowrey, Simon J. Teat, Michael J. Went, Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals Dalton Transactions. ,vol. 3, pp. 4416- 4425 ,(2003) , 10.1039/B307499D